The patients were divided into two groups based on the low and high expression levels of ApoB (n = 46 of ApoBlow and n = 98 of ApoBhigh group in breast cancer patients, n = 29 of ApoBlow and n = 21 of ApoBhigh group in benign breast tumor patients) (Figure 1 and Tables 1 and 2). This evidence concerns the gene APOB and breast carcinoma.